Go Pro
NYSE:AGL

Agilon Health (AGL) Stock Price, News & Analysis

Agilon Health logo
$81.63 +5.80 (+7.65%)
As of 02:02 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Agilon Health Stock (NYSE:AGL)

Advanced

Key Stats

Today's Range
$76.65
▼
$84.35
50-Day Range
$75.85
▼
$129.46
52-Week Range
$7.48
▼
$133.04
Volume
148,252 shs
Average Volume
336,396 shs
Market Capitalization
$1.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$102.25
Consensus Rating
Hold

Company Overview

Agilon Health, Inc. is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company focuses primarily on patients enrolled in Medicare Advantage plans and works with physician groups to coordinate care, improve outcomes and manage healthcare costs.

Agilon provides physicians with technology, analytics, operational support and clinical resources designed to help them manage the health of defined patient populations. Its services may include care coordination, population health management, quality improvement programs and support for risk-based contracting with health plans.

The company was founded in 2016 and became a publicly traded company on the New York Stock Exchange in 2021. Agilon has developed partnerships with independent physician practices in communities across the United States, with its model centered on helping local doctors retain their independence while participating in value-based Medicare care arrangements.

AI Generated. May Contain Errors.

Agilon Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

AGL MarketRank™: 

Agilon Health scored higher than 51% of companies evaluated by MarketBeat, and ranked 504th out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Agilon Health has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on no strong buy ratings, 6 buy ratings, 7 hold ratings, and 2 sell ratings.

  • Upside Potential

    Agilon Health has a consensus price target of $102.25, representing about 25.1% upside from its current price of $81.75.

  • Amount of Analyst Coverage

    Agilon Health has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Agilon Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Agilon Health are expected to grow in the coming year, from ($2.90) to $1.20 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Agilon Health is -5.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Agilon Health is -5.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Agilon Health has a P/B Ratio of 10.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Agilon Health's valuation and earnings.
  • Percentage of Shares Shorted

    6.42% of the float of Agilon Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Agilon Health has a short interest ratio ("days to cover") of 6.23.
  • Change versus previous month

    Short interest in Agilon Health has recently decreased by 2.77%, indicating that investor sentiment is improving.
  • Dividend Yield

    Agilon Health does not currently pay a dividend.

  • Dividend Growth

    Agilon Health does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on EPS estimates, Agilon Health will have a dividend payout ratio of 150.00% in the coming year. This indicates that Agilon Health may not be able to sustain their current dividend.

  • News Sentiment

    Agilon Health has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Agilon Health this week, compared to 7 articles on an average week.
  • Search Interest

    Only 4 people have searched for AGL on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Agilon Health to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Agilon Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.50% of the stock of Agilon Health is held by insiders.

  • Percentage Held by Institutions

    Agilon Health has minimal institutional ownership at this time.

  • Read more about Agilon Health's insider trading history.
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilon Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AGL Stock News Headlines

Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
Agilon Health (AGL) stock trades up, here is why
See More Headlines

AGL Stock Analysis - Frequently Asked Questions

Agilon Health's stock was trading at $17.2125 at the beginning of 2026. Since then, AGL shares have increased by 374.9% and is now trading at $81.7450.

Agilon Health, Inc. (NYSE:AGL) posted its quarterly earnings results on Wednesday, August, 5th. The company reported $1.04 EPS for the quarter, beating the consensus estimate of $0.14 by $0.90. The company earned $1.49 billion during the quarter, compared to analyst estimates of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative trailing twelve-month return on equity of 119.38%.
Read the conference call transcript
.

Agilon Health's stock reverse split before market open on Tuesday, March 31st 2026.The 1-25 reverse split was announced on Wednesday, March 18th 2026. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Agilon Health (AGL) raised $1 billion in an initial public offering (IPO) on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities acted as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

Top institutional investors of Agilon Health include State Street Corp (1.67%), Rubicon Founders LLC (0.63%), Bank of New York Mellon Corp (0.21%) and Tidal Investments LLC (0.08%). Insiders that own company stock include John William Wulf, Karen Mcloughlin, Steven Sell, Diana Mckenzie and Jeffrey A Schwaneke.
View institutional ownership trends
.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agilon Health investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
8/05/2026
Today
9/25/2026
Next Earnings (Estimated)
11/03/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:AGL
CIK
1831097
Fax
N/A
Employees
856
Year Founded
2016

Price Target and Rating

High Price Target
$146.00
Low Price Target
$48.00
Potential Upside/Downside
+23.9%
Consensus Rating
Hold
Rating Score (0-4)
2.27
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
($14.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$391.35 million
Net Margins
-3.92%
Pretax Margin
-4.23%
Return on Equity
-119.38%
Return on Assets
-16.85%

Debt

Debt-to-Equity Ratio
0.07
Current Ratio
1.08
Quick Ratio
1.08

Sales & Book Value

Annual Sales
$5.93 billion
Price / Sales
0.23
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.64 per share
Price / Book
10.80

Miscellaneous

Outstanding Shares
16,790,000
Free Float
16,371,000
Market Cap
$1.39 billion
Optionable
Not Optionable
Beta
3.02

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSE:AGL) was last updated on 9/25/2026 by MarketBeat.com Staff.
From Our Partners